Subset analysis shows early clinical activity supported by biomarker evidence of targeting cancer stem cell pathways driving ...
Data from Phase 1b dose escalation and expansion trial (n=69) shows a favorable safety profile, with manageable adverse events consistent with ...
While retatrutide may have the best weight loss efficacy to date, analysts hold concerns about its tolerability profile compared with best-seller, tirzepatide.
First-in-human healthy volunteers trial showed SYX-5219 was safe and well toleratedSystemic immunomodulation of type 2 inflammation demonstrated ...
When activated in ovarian cancer cells, the receptor for the body's primary stress hormone alters the tumor environment in ...
Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related ...
Study Published in Advances in Redox Research Demonstrated Dose-Dependent Survival Improvement, Reduced Hepatic Copper ...
Three digital multiphase controllers from AOS enable Intel IMVP9.3 Vcore power delivery for high-performance mobile systems.
Allan Young and King’s College, London First time a Selective Endocannabinoid Reuptake Inhibitor (SERI) molecule is dosed in ...
A phase 2 trial of Enterprise Therapeutics’ cystic fibrosis (CF) drug candidate has hit its primary endpoint, furthering the ...
The researchers noted that this marks the first time any technology has achieved 100Gbps-class wireless communication beyond 420GHz, potentially opening a new frontier in high-frequency wireless ...
The new devices, the STDRIVE102P and STDRIVE102BP, are part of the STDRIVE102 series for three-phase brushless motors. Both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results